About this Journal Submit a Manuscript Table of Contents
Journal of Environmental and Public Health
Volume 2012 (2012), Article ID 619381, 9 pages
http://dx.doi.org/10.1155/2012/619381
Review Article

Solar Radiation and Vitamin D: Mitigating Environmental Factors in Autoimmune Disease

Department of Family Medicine, University of Alberta, Suite No. 301, 9509-156 Street, Edmonton, AB, Canada T6G 2M7

Received 3 July 2011; Revised 29 November 2011; Accepted 13 December 2011

Academic Editor: Robin Bernhoft

Copyright © 2012 Gerry K. Schwalfenberg. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Harel and Y. Shoenfeld, “Predicting and preventing autoimmunity, myth or reality?” Annals of the New York Academy of Sciences, vol. 1069, pp. 322–345, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. T. Cantorna and B. D. Mahon, “Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence,” Experimental Biology and Medicine, vol. 229, no. 11, pp. 1136–1142, 2004. View at Scopus
  3. V. Molina and Y. Shoenfeld, “Infection, vaccines and other environmental triggers of autoimmunity,” Autoimmunity, vol. 38, no. 3, pp. 235–245, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. F. de Carvalho, R. M. Pereira, and Y. Shoenfeld, “The mosaic of autoimmunity: the role of environmental factors,” Frontiers in Bioscience, vol. 1, pp. 501–509, 2009. View at Scopus
  5. E. M. Jacobson and Y. Tomer, “The genetic basis of thyroid autoimmunity,” Thyroid, vol. 17, no. 10, pp. 949–961, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Ginanjar, Sumariyono, S. Setiati, and B. Setiyohadi, “Vitamin D and autoimmune disease,” Acta Medica Indonesiana, vol. 39, no. 3, pp. 133–141, 2007. View at Scopus
  7. M. Cutolo, K. Otsa, M. Uprus, S. Paolino, and B. Seriolo, “Vitamin D in rheumatoid arthritis,” Autoimmunity Reviews, vol. 7, no. 1, pp. 59–64, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. A. L. Ponsonby, R. M. Lucas, and I. A. F. Van Der Mei, “UVR, vitamin D and three autoimmune diseases—multiple sclerosis, type 1 diabetes, rheumatoid arthritis,” Photochemistry and Photobiology, vol. 81, no. 6, pp. 1267–1275, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Garland, Powerpoint presentation: Can Diabetes Be Prevented with Vitamin D?Department of Family and Preventative Medicine UCSD School of Medicine, 2008.
  10. G. Schwalfenberg, “Not enough vitamin D: health consequences for Canadians,” Canadian Family Physician, vol. 53, no. 5, pp. 841–854, 2007. View at Scopus
  11. G. K. Schwalfenberg, S. J. Genuis, and M. N. Hiltz, “Addressing vitamin D deficiency in Canada: a public health innovation whose time has come,” Public Health, vol. 124, no. 6, pp. 350–359, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. F. Holick, “Environmental factors that influence the cutaneous production of vitamin D,” American Journal of Clinical Nutrition, vol. 61, supplement 3, pp. 638S–645S, 1995. View at Scopus
  13. J. N. Hathcock, A. Shao, R. Vieth, and R. Heaney, “Risk assessment for vitamin D,” American Journal of Clinical Nutrition, vol. 85, no. 1, pp. 6–18, 2007. View at Scopus
  14. A. W. Norman, “From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health,” American Journal of Clinical Nutrition, vol. 88, no. 2, pp. 491S–499S, 2008. View at Scopus
  15. P. Lips, “Vitamin D physiology,” Progress in Biophysics and Molecular Biology, vol. 92, no. 1, pp. 4–8, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. D. P. Hayes, “The protection afforded by vitamin D against low radiation damage,” International Journal of Low Radiation, vol. 5, no. 4, pp. 368–394, 2008. View at Scopus
  17. G. K. Schwalfenberg, “A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency,” Molecular Nutrition and Food Research, vol. 55, no. 1, pp. 96–108, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. T. T. Wang, B. Dabbas, D. Laperriere et al., “Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin β2 innate immune pathway defective in crohn disease,” Journal of Biological Chemistry, vol. 285, no. 4, pp. 2227–2231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. S. V. Ramagopalan, A. Heger, A. J. Berlanga et al., “A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution,” Genome Research, vol. 20, no. 10, pp. 1352–1360, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Hillert, “The genetics of multiple sclerosis,” Results and Problems in Cell Differentiation, vol. 51, pp. 1–19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Giovannoni and G. Ebers, “Multiple sclerosis: the environment and causation,” Current Opinion in Neurology, vol. 20, no. 3, pp. 261–268, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. E. L. Thacker, F. Mirzaei, and A. Ascherio, “Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis,” Annals of Neurology, vol. 59, no. 3, pp. 499–503, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. T. R. Nielsen, K. Rostgaard, N. M. Nielsen et al., “Multiple sclerosis after infectious mononucleosis,” Archives of Neurology, vol. 64, no. 1, pp. 72–75, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. S. V. Ramagopalan, W. Valdar, D. A. Dyment et al., “Association of infectious mononucleosis with multiple sclerosis,” Neuroepidemiology, vol. 32, no. 4, pp. 257–262, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. P. Pender, “The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis,” Neuroscientist, vol. 17, no. 4, pp. 351–367, 2011. View at Publisher · View at Google Scholar
  26. A. Ascherio and K. Munger, “Epidemiology of multiple sclerosis: from risk factors to prevention,” Seminars in Neurology, vol. 28, no. 1, pp. 17–28, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. E. Handel, L. Jarvis, R. Mclaughlin, A. Fries, G. C. Ebers, and S. V. Ramagopalan, “The epidemiology of multiple sclerosis in Scotland: inferences from hospital admissions,” PLoS ONE, vol. 6, no. 1, article e14606, 2011. View at Publisher · View at Google Scholar
  28. J. S. Sloka, W. E. M. Pryse-Phillips, and M. Stefanelli, “The relation of ultraviolet radiation and multiple sclerosis in Newfoundland,” Canadian Journal of Neurological Sciences, vol. 35, no. 1, pp. 69–74, 2008. View at Scopus
  29. J. G. McLeod, S. R. Hammond, and J. F. Hallpike, “Epidemiology of multiple sclerosis in Australia: with NSW and SA survey results,” Medical Journal of Australia, vol. 160, no. 3, pp. 117–121, 1994. View at Scopus
  30. C. Bisgård, “Seasonal variation in disseminated sclerosis,” Ugeskrift for Laeger, vol. 152, no. 16, pp. 1160–1161, 1990. View at Scopus
  31. D. S. Meier, K. E. Balashov, B. Healy, H. L. Weiner, and C. R. G. Guttmann, “Seasonal prevalence of MS disease activity,” Neurology, vol. 75, no. 9, pp. 799–806, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Salvi, I. Bartolomei, M. H. Smolensky et al., “A seasonal periodicity in relapses of multiple sclerosis? A single-center, population-based, preliminary study conducted in Bologna, Italy,” BMC Neurology, vol. 10, article 105, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. C. J. Willer, D. A. Dyment, A. D. Sadovnick, P. M. Rothwell, T. J. Murray, and G. C. Ebers, “Timing of birth and risk of multiple sclerosis: population based study,” British Medical Journal, vol. 330, no. 7483, pp. 120–123, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. J. F. Kurtzke, “On the fine structure of the distribution of multiple sclerosis,” Acta Neurologica Scandinavica, vol. 43, no. 3, pp. 257–282, 1967. View at Scopus
  35. Y. Dong, N. Pollock, I. S. Stallmann-Jorgensen et al., “Low 25-hydroxyvitamin D levels in adolescents: race, season, adiposity, physical activity, and fitness,” Pediatrics, vol. 125, no. 6, pp. 1104–1111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. M. G. Bischof, G. Heinze, and H. Vierhapper, “Vitamin D status and its relation to age and body mass index,” Hormone Research, vol. 66, no. 5, pp. 211–215, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. K. L. Munger, T. Chitnis, and A. Ascherio, “Body size and risk of MS in two cohorts of US women,” Neurology, vol. 73, no. 19, pp. 1543–1550, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Dwyer, I. Van Der Mei, A. L. Ponsonby et al., “Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis,” Neurology, vol. 71, no. 8, pp. 583–589, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Westlund, “Distribution and mortality time trend of multiple sclerosis and some other diseases in Norway,” Acta Neurologica Scandinavica, vol. 46, no. 4, pp. 455–483, 1970. View at Scopus
  40. K. L. Munger, S. M. Zhang, E. O'Reilly et al., “Vitamin D intake and incidence of multiple sclerosis,” Neurology, vol. 62, no. 1, pp. 60–65, 2004. View at Scopus
  41. S. M. Kimball, M. R. Ursell, P. O'Connor, and R. Vieth, “Safety of vitamin D3 in adults with multiple sclerosis,” American Journal of Clinical Nutrition, vol. 86, no. 3, pp. 645–651, 2007. View at Scopus
  42. M. S. Stein, Y. Liu, O. M. Gray et al., “A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis,” Neurology, vol. 77, no. 17, pp. 1611–1618, 2011. View at Publisher · View at Google Scholar
  43. J. M. Burton, S. Kimball, R. Vieth et al., “A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis,” Neurology, vol. 74, no. 23, pp. 1852–1859, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Olmos, R. A'Hern, D. A. Heaton et al., “The significance of the concordance rate for Type 1 (insulin-dependent) diabetes in identical twins,” Diabetologia, vol. 31, no. 10, pp. 747–750, 1988. View at Scopus
  45. H. Hyöty and K. Taylor, “The role of viruses in human diabetes,” Diabetologia, vol. 45, no. 10, pp. 1353–1361, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. C. H. Williams, S. Oikarinen, S. Tauriainen, K. Salminen, H. Hyoty, and G. Stanway, “Molecular analysis of an echovirus 3 strain isolated from an individual concurrently with appearance of islet cell and IA-2 autoantibodies,” Journal of Clinical Microbiology, vol. 44, no. 2, pp. 441–448, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. B. Lernmark, K. Lynch, and A. Lernmark, “Cord blood islet autoantibodies are related to stress in the mother during pregnancy,” Annals of the New York Academy of Sciences, vol. 1079, pp. 345–349, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. S. B. Mohr, C. F. Garland, E. D. Gorham, and F. C. Garland, “The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide,” Diabetologia, vol. 51, no. 8, pp. 1391–1398, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Sloka, M. Grant, and L. A. Newhook, “Time series analysis of ultraviolet B radiation and type 1 diabetes in Newfoundland,” Pediatric Diabetes, vol. 9, no. 2, pp. 81–86, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Sloka, M. Grant, and L. A. Newhook, “The geospatial relation between UV solar radiation and type 1 diabetes in Newfoundland,” Acta Diabetologica, vol. 47, no. 1, pp. 73–78, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. P. M. Rothwell, A. Staines, P. Smail, E. Wadsworth, and P. McKinney, “Seasonality of birth of patients with childhood diabetes in Britain,” British Medical Journal, vol. 312, no. 7044, pp. 1456–1457, 1996. View at Scopus
  52. H. K. Akerblom, D. J. Ballard, B. Bauman et al., “Geographic patterns of childhood insulin-dependent diabetes mellitus,” Diabetes, vol. 37, no. 8, pp. 1113–1119, 1988.
  53. B. Littorin, L. Nyström, B. Gullberg et al., “Increasing body mass index at diagnosis of diabetes in young adult people during 1983–1999 in the Diabetes Incidence Study in Sweden (DISS),” Journal of Internal Medicine, vol. 254, no. 3, pp. 251–256, 2003. View at Publisher · View at Google Scholar
  54. B. Littorin, P. Blom, A. Schölin et al., “Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS),” Diabetologia, vol. 49, no. 12, pp. 2847–2852, 2006. View at Publisher · View at Google Scholar
  55. L. Marjamäki, S. Niinistö, M. G. Kenward et al., “Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring,” Diabetologia, vol. 53, no. 8, pp. 1599–1607, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. C. S. Zipitis and A. K. Akobeng, “Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis,” Archives of Disease in Childhood, vol. 93, no. 6, pp. 512–517, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. E. Hyppönen, E. Läärä, A. Reunanen, M.-R. Järvelin, and S. M. Virtanen, “Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study,” The Lancet, vol. 358, no. 9292, pp. 1500–1503, 2001. View at Publisher · View at Google Scholar
  58. L. C. Stene and G. Joner, “Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study,” American Journal of Clinical Nutrition, vol. 78, no. 6, pp. 1128–1134, 2003. View at Scopus
  59. L. C. Stene, J. Ulriksen, P. Magnus, and G. Joner, “Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring,” Diabetologia, vol. 43, no. 9, pp. 1093–1098, 2000. View at Publisher · View at Google Scholar · View at Scopus
  60. S. S. Harris, “Vitamin D in type 1 diabetes prevention,” Journal of Nutrition, vol. 135, no. 2, pp. 323–325, 2005. View at Scopus
  61. V. Harjutsalo, L. Sjöberg, and J. Tuomilehto, “Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study,” The Lancet, vol. 371, no. 9626, pp. 1777–1782, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. P. Jarvinen and K. Aho, “Twin studies in rheumatic disease,” Seminars in Arthritis and Rheumatism, vol. 24, no. 1, pp. 19–28, 1994. View at Publisher · View at Google Scholar · View at Scopus
  63. Y. Kochi, A. Suzuki, R. Yamada, and K. Yamamoto, “Genetics of rheumatoid arthritis: underlying evidence of ethnic differences,” Journal of Autoimmunity, vol. 32, no. 3-4, pp. 158–162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. R. L. Wilder and L. J. Crofford, “Do infectious agents cause rheumatoid arthritis?” Clinical Orthopaedics and Related Research, no. 265, pp. 36–41, 1991. View at Scopus
  65. A. Krause, T. Kamradt, and G. R. Burmester, “Potential infectious agents in the induction of arthritides,” Current Opinion in Rheumatology, vol. 8, no. 3, pp. 203–209, 1996. View at Scopus
  66. B. Gonzalez, C. Larrañaga, O. León et al., “Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis,” Journal of Rheumatology, vol. 34, no. 6, pp. 1336–1340, 2007.
  67. L. Klareskog, L. Padyukov, and L. Alfredsson, “Smoking as a trigger for inflammatory rheumatic diseases,” Current Opinion in Rheumatology, vol. 19, no. 1, pp. 49–54, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Cutolo, “Solar light effects on onset/relapses and circannual/circadian symptomatology in rheumatoid arthritis,” Clinical and Experimental Rheumatology, vol. 21, no. 2, pp. 148–150, 2003. View at Scopus
  69. E. Zold, P. Szodoray, J. Gaal et al., “Vitamin D deficiency in undifferentiated connective tissue disease,” Arthritis Research and Therapy, vol. 10, no. 5, article R123, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Cutolo, K. Otsa, K. Laas et al., “Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe,” Clinical and Experimental Rheumatology, vol. 24, no. 6, pp. 702–704, 2006. View at Scopus
  71. W. W. Buchanan, L. G. Gregoire, and H. M. Buchanan, “Month of birth and rheumatoid arthritis,” The Lancet, vol. 2, no. 8557, p. 517, 1987. View at Scopus
  72. M. Rossini, S. Maddali Bongi, G. La Montagna et al., “Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability,” Arthritis Research and Therapy, vol. 12, no. 6, article R216, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. G. Westhoff, R. Rau, and A. Zink, “Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index,” Arthritis and Rheumatism, vol. 56, no. 11, pp. 3575–3582, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. K. G. Oen and M. Cheang, “Epidemiology of chronic arthritis in childhood,” Seminars in Arthritis and Rheumatism, vol. 26, no. 3, pp. 575–591, 1996. View at Publisher · View at Google Scholar · View at Scopus
  75. M. M. Schwartz, P. Simpson, K. L. Kerr, and J. N. Jarvis, “Juvenile rheumatoid arthritis in African Americans,” Journal of Rheumatology, vol. 24, no. 9, pp. 1826–1829, 1997. View at Scopus
  76. L. A. Merlino, J. Curtis, T. R. Mikuls, J. R. Cerhan, L. A. Criswell, and K. G. Saag, “Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study,” Arthritis and Rheumatism, vol. 50, no. 1, pp. 72–77, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. Z. Andjelkovic, J. Vojinovic, N. Pejnovic et al., “Disease modifying and immunomodulatory effects of high dose 1α(OH) D3 in rheumatoid arthritis patients,” Clinical and Experimental Rheumatology, vol. 17, no. 4, pp. 453–456, 1999. View at Scopus
  78. M. F. Prummel, T. Strieder, and W. M. Wiersinga, “The environment and autoimmune thyroid diseases,” European Journal of Endocrinology, vol. 150, no. 5, pp. 605–618, 2004. View at Publisher · View at Google Scholar · View at Scopus
  79. Y. Tomer and T. F. Davies, “The genetic susceptibility to Graves' disease,” Bailliere's Clinical Endocrinology and Metabolism, vol. 11, no. 3, pp. 431–450, 1997. View at Publisher · View at Google Scholar · View at Scopus
  80. T. H. Brix, P. S. Hansen, K. O. Kyvik, and L. Hegedüs, “Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case-control study,” Archives of Internal Medicine, vol. 160, no. 5, pp. 661–666, 2000. View at Scopus
  81. G. Tamer, S. Arik, I. Tamer, and D. Coksert, “Relative vitamin D insufficiency in Hashimoto's thyroiditis,” Thyroid, vol. 21, no. 8, pp. 891–896, 2011. View at Publisher · View at Google Scholar
  82. S. Kivity, N. Agmon-Levin, M. Zisappl et al., “Vitamin D and autoimmune thyroid diseases,” Cellular and Molecular Immunology, vol. 8, no. 3, pp. 243–247, 2011. View at Publisher · View at Google Scholar
  83. G. E. Krassas, K. Tziomalos, N. Pontikides, H. Lewy, and Z. Laron, “Seasonality of month of birth of patients with Graves' and Hashimoto's diseases differ from that in the general population,” European Journal of Endocrinology, vol. 156, no. 6, pp. 631–636, 2007. View at Publisher · View at Google Scholar · View at Scopus
  84. D. I. W. Phillips, D. J. P. Barker, and J. A. Morris, “Seasonality of thyrotoxicosis,” Journal of Epidemiology and Community Health, vol. 39, no. 1, pp. 72–74, 1985. View at Scopus
  85. M. E. Spehlmann, A. Z. Begun, J. Burghardt, P. Lepage, A. Raedler, and S. Schreiber, “Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study,” Inflammatory Bowel Diseases, vol. 14, no. 7, pp. 968–976, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. F. Carbonnel, P. Jantchou, E. Monnet, and J. Cosnes, “Environmental risk factors in Crohn's disease and ulcerative colitis: an update,” Gastroentérologie Clinique et Biologique, vol. 33, supplement 3, pp. S145–S157, 2009.
  87. J. H. Ooi, J. Chen, and M. T. Cantorna, “Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors?” Molecular Aspects of Medicine, vol. 33, no. 1, pp. 77–82, 2012. View at Publisher · View at Google Scholar
  88. J. Gilman, F. Shanahan, and K. D. Cashman, “Determinants of vitamin D status in adult Crohn's disease patients, with particular emphasis on supplemental vitamin D use,” European Journal of Clinical Nutrition, vol. 60, no. 7, pp. 889–896, 2006. View at Publisher · View at Google Scholar · View at Scopus
  89. A. J. Joseph, B. George, A. B. Pulimood, M. S. Seshadri, and A. Chacko, “25 (OH) vitamin D level in Crohn's disease: association with sun exposure & disease activity,” Indian Journal of Medical Research, vol. 130, no. 2, pp. 133–137, 2009. View at Scopus
  90. V. Nerich, E. Monnet, A. Weill et al., “Fine-scale geographic variations of inflammatory bowel disease in france: correlation with socioeconomic and house equipment variables,” Inflammatory Bowel Diseases, vol. 16, no. 5, pp. 813–821, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. A. Ekbom, C. Helmick, M. Zack, and H. O. Adami, “The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden,” Gastroenterology, vol. 100, no. 2, pp. 350–358, 1991. View at Scopus
  92. M. A. Mendall, A. Viran Gunasekera, B. Joseph John, and D. Kumar, “Is obesity a risk factor for Crohn's disease?” Digestive Diseases and Sciences, vol. 56, no. 3, pp. 837–844, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. H. M. Pappa, C. M. Gordon, T. M. Saslowsky et al., “Vitamin D status in children and young adults with inflammatory bowel disease,” Pediatrics, vol. 118, no. 5, pp. 1950–1961, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. P. H. A. Bours, J. P. M. Wielders, J. R. Vermeijden, and A. van de Wiel, “Seasonal variation of serum 25-hydroxyvitamin D levels in adult patients with inflammatory bowel disease,” Osteoporosis International, vol. 22, no. 11, pp. 2857–2867, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. S. P. Jørgensen, J. Agnholt, H. Glerup et al., “Clinical trial: vitamin D3 treatment in Crohn's disease—a randomized double-blind placebo-controlled study,” Alimentary Pharmacology and Therapeutics, vol. 32, no. 3, pp. 377–383, 2010. View at Publisher · View at Google Scholar
  96. D. R. Terrell, L. A. Beebe, S. K. Vesely, B. R. Neas, J. B. Segal, and J. N. George, “The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports,” American Journal of Hematology, vol. 85, no. 3, pp. 174–180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. D. Provan, R. Stasi, A. C. Newland et al., “International consensus report on the investigation and management of primary immune thrombocytopenia,” Blood, vol. 115, no. 2, pp. 168–186, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. G. K. Schwalfenberg and S. J. Genuis, “Vitamin D supplementation in a nursing home population,” Molecular Nutrition and Food Research, vol. 54, no. 8, pp. 1072–1076, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. W. B. Grant, G. K. Schwalfenberg, S. J. Genuis, and S. J. Whiting, “An estimate of the economic burden and premature deaths due to vitamin D deficiency in Canada,” Molecular Nutrition and Food Research, vol. 54, no. 8, pp. 1172–1181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. W. B. Grant, H. S. Cross, C. F. Garland et al., “Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe,” Progress in Biophysics and Molecular Biology, vol. 99, no. 2-3, pp. 104–113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. G. Bjelakovic, L. L. Gluud, D. Nikolova et al., “Vitamin D supplementation for prevention of mortality in adults,” Cochrane Database of Systematic Reviews, no. 7, article CD007470, 2011.